Cervical Cancer Diagnostic Testing Market Size & Share, 2028

Cervical Cancer Diagnostic Testing Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (PAP Testing, HPV Testing, Colposcopy, Cervical Biopsies, Cystoscopy, and Others) and Service Provider (Diagnostics and Research Laboratories, Hospitals and Clinics, Specialty Clinics, and Home Care services) and Geography

Publication Month : Dec 2021

  • Report Code : TIPRE00016639
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 160
Inquire Before Buy

PRICING

$4550

$2730

The cervical cancer diagnostic testing market is projected to reach US$ 7,165.92 million by 2028 from US$ 5,141.25 million in 2021; it is expected to grow at a CAGR of 4.9% from 2021 to 2028.

Cervical cancer has a significant mortality rate (almost 50%), which can be lowered with early detection and prevention. Precancerous alterations offer opportunities for prevention and treatment because disease progression is often delayed. However, due to a lack of awareness or access to diagnostic services, many cases are detected at later stages of illness progression. Human Papillomavirus (HPV) is a primary cause of cervical cancer that is typically transmitted through sexual contact. There are over 100 HPV strains, and 13 of which are high-risk or carcinogenic. The active gene - E6 or E7 - determines whether an HPV strain is high or low risk. E6 binds to p53, causing proteolytic destruction. E7, on the other hand, binds to retinoblastoma; the binding displaces previously attached transcription factors, resulting in the cell cycle being stopped and apoptosis regulation being inhibited. The HPV test detects human papillomavirus in cervical cells. Other screening approaches employed in low-resource areas of developing countries are HPV DNA testing and visual inspection. Cervical screening on a regular basis aids in an early detection of cervical cancer, lowering the mortality rate from the disease. Every three years, all women between the ages of 21 and 65 are advised to have a Pap test, and women between the ages of 30 and 65 are advised to have both a Pap and an HPV test. In terms of revenue, this type dominated the cervical cancer screening market in 2021, and it is expected to continue its dominance during the forecast period.


Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Cervical Cancer Diagnostic Testing Market: Strategic Insights

cervical-cancer-diagnostic-testing-market
Market Size Value inUS$ 5,141.25 million in 2021
Market Size Value byUS$ 7,165.92 million by 2028
Growth rateCAGR of 4.9% from 2021 to 2028
Forecast Period2021-2028
Base Year2021
Analyst Image

Akshay

Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

Lucrative Regions for Cervical Cancer Diagnostic Testing Market

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

Market Insights
Increasing Prevalence of Cancer to Drive Cervical Cancer Diagnostic Testing Market Growth During Forecast Period


Cancer has emerged as a leading cause of death across the world. According to the World Health Organization (WHO), cancer was the first leading cause of death in the people of below 70 years in 183 countries and fourth leading cause of death in 123 countries worldwide in 2019. In addition, according to data published by the WHO in March 2021, ~10 million deaths occurred in 2020 due to different cancer types. The rising incidence of cervical cancer among women worldwide drives the cervical cancer diagnostic testing market growth. According to the WHO, more than 270,000 deaths of women are recorded due to cervical cancer each year. Cervical cancer mortality rates are greater in low-income countries due to the late diagnosis of the disease. The market is predicted to grow in the coming years due to the increasing acceptance of cervical cancer diagnostic tests for the early detection of the disease.

The increasing prevalence of cancer has created burden on the healthcare systems across the world. According to International Agency for Research on Cancer (IARC), the global burden of new cancer cases is estimated to reach ~ 27.5 million by 2040, and the disease is likely to be a cause of ~163 million deaths by that year. Factors such as lifestyle changes, smoking, reduced physical activities, and uncertain health and climatic conditions are would lead to even greater burden of cancer in the world in the coming years.

Type-Based Insights

Based on type, the cervical cancer diagnostic testing market is segmented into PAP testing, HPV testing, colposcopy, cervical biopsies, cystoscopy, and others. In 2021, the PAP testing segment held the largest share of the market, and it is estimated to register the highest CAGR during 2021–2028.

Cervical Cancer Diagnostic Testing Market, by Type – 2021 and 2028

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

Service Provider-Based Insights

Based on the service provider, the market is segmented into research, diagnostics and research laboratories, hospitals and clinics, specialty clinics, and home care services. In 2021, the diagnostics and research laboratories segment held the largest share of the market and is expected to register the highest CAGR in the market during 2021–2028.

Companies operating in the cervical cancer diagnostic testing market are adopting various strategies such as, product innovations, to meet the evolving customer demands across the world and maintain their brand name in the global market.

Cervical Cancer Diagnostic Testing Market – Segmentation

The cervical cancer diagnostic testing market is segmented on the basis of type, and service provider. Based on type, the market is sub-segmented into PAP testing, HPV testing, colposcopy, cervical biopsies, cystoscopy, and others. Based on the service provider, the market is further segmented into diagnostics and research laboratories, hospitals and clinics, specialty clinics, and home care services.
 
In terms of geography, the cervical cancer diagnostic testingmarket is segmented into North America (the US, Canada, and Mexico), Europe (France, Germany, Italy, the UK, Spain, and Rest of Europe), Asia Pacific (Australia, China, India, Japan, South Korea, and Rest of APAC), the Middle East & Africa (Saudi Arabia, South Africa, the UAE, and Rest of MEA), and South and Central America (Brazil, Argentina, and Rest of SCAM).

Company Profiles

  • F. Hoffmann-La Roche Ltd.
  • Abbott
  • Quest Diagnostics Incorporated
  • QIAGEN
  • Hologic, Inc.
  • DYSIS Medical Inc.
  • Femasys Inc.
  • Guided Therapeutics, Inc.
  • Cooper Companies, Inc.
  • BD
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Type, Service Provider, and Geography

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States

Frequently Asked Questions


What is Cervical Cancer Diagnostic Testing?

Cervical Cancer refers to cancer that occurs in the cells of the cervix i.e. the lower part of the uterus that connects to the vagina. In 90% of the cases, cervical malignancies occur due to the HPV infection and are diagnosed through smear screening.

What are the factors impacting the cervical cancer diagnostic testing market?

The factors that are driving and restraining factors that will affect the cervical cancer diagnostic testing market in the coming years. Factors such as the increasing prevalence of cancer and the rise in HPV infections are driving the market growth. However, less number of commercially available vaccines for the treatment of cancer are likely to hamper the growth of the market.

Who are the major players in the cervical cancer diagnostic testing market?

The cervical cancer diagnostic testing market majorly consists of the players such as as F. Hoffmann-La Roche Ltd., Abbott, Quest Diagnostics Incorporated, QIAGEN, Hologic, Inc., DYSIS Medical Inc., Femasys Inc., Guided Therapeutics, Inc, Cooper Companies, Inc., BD are amongst others.

What is the market value of the cervical cancer diagnostic testing market based on region?

The global cervical cancer diagnostic testing market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. The North American area holds the largest market for aesthetic skin devices. The United States held the most significant cervical cancer diagnostic testing market and is expected to grow due to factors such as high awareness about disease prevention among women in the region, as well as to the many initiatives launched to prevent cervical cancer, which have increased the reach of insurance coverage for cervical screening tests, especially for low-income women, and others.

Which is the most influencing segment growing in the cervical cancer diagnostic testing market report?

The cervical cancer diagnostic testing market based on type is segmented into PAP testing, HPV testing, colposcopy, cervical biopsies, cystoscopy, others. In 2021, the PAP Testing segment accounted for the highest share. Besides, the HPV testing segment is expected to grow at a CAGR of 5.5% in the forecast period.

Which region is expected to witness significant demand for the cervical cancer diagnostic testing market in the coming years?

Asia Pacific is registered as the fastest-growing region in the global cervical cancer diagnostic testing market. The market is this region is expected to grow significantly in countries such as China, Japan, and India. The market is driven by the increasing prevalence of cervical cancer in developing countries, including China, India, Malaysia, Japan, South Korea, and Australia.

The List of Companies - Cervical Cancer Diagnostic Testing Market

  1. F. HOFFMANN-LA ROCHE LTD.
  2. Abbott
  3. Quest Diagnostics Incorporated
  4. QIAGEN
  5. Hologic, Inc.
  6. DYSIS Medical Inc
  7. Femasys Inc.
  8. GUIDED THERAPEUTICS, INC
  9. Cooper Companies, Inc.
  10. BD

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Cervical Cancer Diagnostic Testing Market